ECO Animal Health Regulatory Approval
April 02 2019 - 2:00AM
UK Regulatory
TIDMEAH
2 April 2019
ECO Animal Health Group plc
(AIM: EAH)
ECO RECEIVES EUROPEAN MARKETING AUTHORISATION FOR AIVLOSIN® FOR
BREEDING CHICKENS
ECO Animal Health Group plc (the "Group") is pleased to announce
that its subsidiary ECO Animal Health Limited (ECO) has received a
marketing authorisation from the European Medicines Agency (EMA)
for the use of Aivlosin® 625 mg/g Water Soluble Granules (WSG) in
breeding chickens.
This approval allows ECO to market Aivlosin® 625 mg/g WSG in
Europe for the treatment and metaphylaxis of respiratory infections
caused by Mycoplasma gallisepticum in breeding chickens producing
eggs, for hatching broiler stock and for replacement layers.
Aivlosin®, ECO's patented antimicrobial, is used under
veterinary prescription for the treatment of a variety of
economically important respiratory and enteric (gut) diseases in
poultry and pigs.
Marc Loomes, CEO, commented: "The EU has five per cent of the
world's layer and ten per cent of the world's broiler parent stock.
This marketing authorisation is very significant as it provides an
opportunity to roll out the approval beyond the EU into the
multi-million dollar large international poultry markets. This will
enable ECO to capitalise on the considerable global potential for
Aivlosin® which offers a safe and highly effective medication for
Mycoplasma infections in high value breeding birds".
The information contained within this announcement is deemed by
the Group to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No. 596/2014 ("MAR").Upon the
publication of this announcement via a Regulatory Information
Service ("RIS"), this inside information is now considered to be in
the public domain.
Contacts:
ECO Animal Health Group plc
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
IFC Advisory Ltd 0203 934 6630
Graham Herring, Miles Nolan
N+1 Singer (Nominated Adviser and Joint Broker) 020 7496 3000
Mark Taylor, James White, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
ECO Animal Health Group plc is a leader in the development,
registration and marketing of pharmaceutical products for animals.
Our products for these global growth markets promote well-being.
Our financial goals are achieved through the careful and
responsible application of science to generate value for our
shareholders
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190401005683/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
April 02, 2019 02:00 ET (06:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2023 to Apr 2024